Expression of recombinant West Nile virus prM protein fused to an affinity tag for use as a diagnostic antigen

Journal of Virological Methods

Volumn 175, Issue 1, 2011, Pages 20-27

  Setoh, Y X ^a   Hobson Peters, J ^a,b   Prow, N A ^a   Young, P R ^a   Hall, R A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Australian Biosecurity Cooperative Research Centre for Emerging Infectious Disease   (Australia)

Author keywords

Diagnostic antigen; Flavivirus; His tag; Horse serum; PrM; V5 tag; West Nile virus

Indexed keywords

DIAGNOSTIC AGENT; EPITOPE; M PROTEIN; POLYHISTIDINE TAG; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; VIRUS ANTIGEN; VIRUS FUSION PROTEIN;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN STRUCTURE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; WEST NILE FLAVIVIRUS;

AEDES; AFFINITY LABELS; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HORSES; IMMUNE SERA; RECOMBINANT FUSION PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRAL STRUCTURAL PROTEINS; WEST NILE FEVER; WEST NILE VIRUS;

EQUIDAE; FLAVIVIRUS; WEST NILE VIRUS;

EID: 79958019117     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.04.010     Document Type: Article

References (41)

1. Adams S.C., Broom A.K., Sammels L.M., Hartnett A.C., Howard M.J., Coelen R.J., Mackenzie J.S., Hall R.A. Glycosylation and antigenic variation among Kunjin virus isolates. Virology 1995, 206:49-56.
2. Alexandrov N. Structural argument for N-terminal initiation of protein folding. Protein Sci. 1993, 2:1989-1991.
3. Allison S.L., Stadler K., Mandl C.W., Kunz C., Heinz F.X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 1995, 69:5816-5820.
4. Bogachek M.V., Protopopova E.V., Ternovoi V.A., Kachko A.V., Ivanova A.V., Ivanisenko V.A., Shvalov A.N., Loktev V.B. Immunochemical properties of the West Nile virus prM protein and the C-terminal fragment of the M protein. Mol. Biol. 2007, 41:5-13.
5. Bunning M.L., Bowen R.A., Cropp B., Sullivan K., Davis B., Komar N., Godsey M., Baker D., Hettler D., Holmes D., Mitchell C.J. Experimental infection of horses with West Nile virus and their potential to infect mosquitoes and serve as amplifying hosts. Ann. N. Y. Acad. Sci. 2001, 951:338-339.
6. Cardosa M.J., Wang S.M., Sum M.S., Tio P.H. Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses. BMC Microbiol. 2002, 2:9.
7. CDC, 2010. West Nile virus: Statistics, surveillance, and control. (accessed 19.10.2010.).
8. Chambers T.J., Droll D.A., Jiang X., Wold W.S., Nickells J.A. JE Nakayama/JE SA14-14-2 virus structural region intertypic viruses: biological properties in the mouse model of neuroinvasive disease. Virology 2007, 366:51-61.
9. Chang G.J., Hunt A.R., Davis B. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. J. Virol. 2000, 74:4244-4252.
10. Clark D.C., Lobigs M., Lee E., Howard M.J., Clark K., Blitvich B.J., Hall R.A. In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein. J. Gen. Virol. 2007, 88:1175-1183.
11. Crill W.D., Trainor N.B., Chang G.J. A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J. Gen. Virol. 2007, 88:1169-1174.
12. Damle R.G., Yeolekar L.R., Rao B.L. Strain analysis and epitope mapping of West Nile virus using monoclonal antibodies. Acta Virol. 1998, 42:389-395.
13. Davis B.S., Chang G.J., Cropp B., Roehrig J.T., Martin D.A., Mitchell C.J., Bowen R., Bunning M.L. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 2001, 75:4040-4047.
14. Devine P.A. West Nile virus infection. Primary Care Update for OB/GYNS 2003, 10:191-195.
15. Fonseca B.A., Pincus S., Shope R.E., Paoletti E., Mason P.W. Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. Vaccine 1994, 12:279-285.
16. Hamann T., Laursen T., Moller B.L. Functional expression of N-terminally tagged membrane bound cytochrome P450. Protein Expr. Purif. 2009, 68:18-21.
17. Hanna S.L., Pierson T.C., Sanchez M.D., Ahmed A.A., Murtadha M.M., Doms R.W. N-linked glycosylation of West Nile virus envelope proteins influences particle assembly and infectivity. J. Virol. 2005, 79:13262-13274.
18. Heinz F.X., Allison S.L. Structures and mechanisms in flavivirus fusion. Adv. Virus Res. 2000, 55:231-269.
19. Heinz F.X., Allison S.L., Stiasny K., Schalich J., Holzmann H., Mandl C.W., Kunz C. Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine 1995, 13:1636-1642.
20. Hobson-Peters, J., 2010. Characterisation and recombinant expression of antigens for the rapid diagnosis of West Nile virus infections. PhD Thesis. The University of Queensland, Australia.
21. Hobson-Peters J., Toye P., Sanchez M.D., Bossart K.N., Wang L.F., Clark D.C., Cheah W.Y., Hall R.A. A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection. J. Gen. Virol. 2008, 89:3063-3072.
22. Hobson-Peters, J., Arevalo, C., Cheah, W.Y., Blitvich, B.J., Tan, C.S., Sandis, A., Araya, L.N., Hernandez, J.L., Toye, P. Hall, R.A., 2011. Detection of antibodies to West Nile virus in horses, Costa Rica, 2004. Vector Borne Zoonotic Dis. doi:10.1089/vbz.2010.0198.
23. Holbrook M.R., Shope R.E., Barrett A.D. Use of recombinant E protein domain III-based enzyme-linked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. J. Clin. Microbiol. 2004, 42:4101-4110.
24. Konishi E., Mason P.W. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J. Virol. 1993, 67:1672-1675.
25. Konishi E., Yamaoka M., Khin Sane W., Kurane I., Mason P.W. Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes. J. Virol. 1998, 72:4925-4930.
26. Lanciotti R.S., Kerst A.J., Nasci R.S., Godsey M.S., Mitchell C.J., Savage H.M., Komar N., Panella N.A., Allen B.C., Volpe K.E., Davis B.S., Roehrig J.T. Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J. Clin. Microbiol. 2000, 38:4066-4071.
27. Lanciotti R.S., Roehrig J.T., Deubel V., Smith J., Parker M., Steele K., Crise B., Volpe K.E., Crabtree M.B., Scherret J.H., Hall R.A., MacKenzie J.S., Cropp C.B., Panigrahy B., Ostlund E., Schmitt B., Malkinson M., Banet C., Weissman J., Komar N., Savage H.M., Stone W., McNamara T., Gubler D.J. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999, 286:2333-2337.
28. Li L., Lok S.M., Yu I.M., Zhang Y., Kuhn R.J., Chen J., Rossmann M.G. The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 2008, 319:1830-1834.
29. Lin Y.J., Wu S.C. Histidine at residue 99 and the transmembrane region of the precursor membrane prM protein are important for the prM-E heterodimeric complex formation of Japanese encephalitis virus. J. Virol. 2005, 79:8535-8544.
30. Lorenz I.C. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J. Virol. 2002, 76:5480-5491.
31. Lorenz I.C., Allison S.L., Heinz F.X., Helenius A. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J. Virol. 2002, 76:5480-5491.
32. Nisbet D.J., Lee K.J., van den Hurk A.F., Johansen C.A., Kuno G., Chang G.J., Mackenzie J.S., Ritchie S.A., Hall R.A. Identification of new flaviviruses in the Kokobera virus complex. J. Gen. Virol. 2005, 86:121-124.
33. Oceguera L.F., Patiris P.J., Chiles R.E., Busch M.P., Tobler L.H., Hanson C.V. Flavivirus serology by Western blot analysis. Am. J. Trop. Med. Hyg. 2007, 77:159-163.
34. Pincus S., Mason P.W., Konishi E., Fonseca B.A., Shope R.E., Rice C.M., Paoletti E. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology 1992, 187:290-297.
35. Roberson J.A., Crill W.D., Chang G.J. Differentiation of West Nile and St Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity. J. Clin. Microbiol. 2007, 45:3167-3174.
36. Roehrig J.T., Mathews J.H., Trent D.W. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology 1983, 128:118-126.
37. Sanchez M.D., Pierson T.C., McAllister D., Hanna S.L., Puffer B.A., Valentine L.E., Murtadha M.M., Hoxie J.A., Doms R.W. Characterization of neutralizing antibodies to West Nile virus. Virology 2005, 336:70-82.
38. Stiasny K., Kiermayr S., Holzmann H., Heinz F.X. Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J. Virol. 2006, 80:9557-9568.
39. Throsby M., Geuijen C., Goudsmit J., Bakker A.Q., Korimbocus J., Kramer R.A., Clijsters-van der Horst M., de Jong M., Jongeneelen M., Thijsse S., Smit R., Visser T.J., Bijl N., Marissen W.E., Loeb M., Kelvin D.J., Preiser W., ter Meulen J., de Kruif J. Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus. J. Virol. 2006, 80:6982-6992.
40. Wang P.G., Kudelko M., Lo J., Siu L.Y., Kwok K.T., Sachse M., Nicholls J.M., Bruzzone R., Altmeyer R.M., Nal B. Efficient assembly and secretion of recombinant subviral particles of the four dengue serotypes using native prM and E proteins. PLoS One 2009, 4:e8325.
41. Yang D.K., Kweon C.H., Kim B.H., Lim S.I., Kwon J.H., Kim S.H., Song J.Y., Han H.R. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice. J. Vet. Sci. 2005, 6:125-133.